vaccines and global health :: ethics and policy

….from the Center for Vaccine Ethics and Policy…GE2P2 Global Foundation

Menu

Skip to content

Home
about us
ethics & policy consulting
- CVEP: Fiduciary Transition [May-June 2015]
week in review
- #53112 (no title)
symposium resources
keynotes, papers, panels
- Observations and Comment :: Beware of Kingdoms bearing Gifts – Gavi, Yemen and $25 million from Saudi Arabia :: 3 Nov 2016

Time for Africa to future-proof, starting with COVID-19

Posted on 8 February 2022 by davidrcurry

Lancet Infectious Diseases
Feb 2022 Volume 22 Number 2 p151-296, e41-e65
https://www.thelancet.com/journals/laninf/issue/current

Editorial
Time for Africa to future-proof, starting with COVID-19
The Lancet Infectious Diseases

Share this:

Facebook
X

Like Loading...

Related

This entry was posted in Uncategorized. Bookmark the permalink.

Post navigation

← Safety and immunogenicity of an inactivated COVID-19 vaccine, BBIBP-CorV, in people younger than 18 years: a randomised, double-blind, controlled, phase 1/2 trial

Can early measles vaccination control both measles and respiratory syncytial virus infections? →

Search

Archives

Meta

Create account
Log in

Blog at WordPress.com.

Reblog
Subscribe Subscribed
- vaccines and global health :: ethics and policy
- Already have a WordPress.com account? Log in now.

%d